Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

Just a thought but fact that Astra combo trial was clearly mentioned in business update, and combo trial includes Head and Neck Cancer I would not be surprised to see Astra licence both of those constructs.

From update;

Given the promising early data in head and neck and anal cancers, Advaxis is actively pursuing opportunities to continue development through investigator-sponsored trials (ISTs) or other third-party approaches.

Merck has Prostate

Bristol has Cervical

Amgen has NEO.